Mackensen & Company Inc

Inotek Pharmaceuticals is a privately held biotechnology company based in Lexington, MA, specializing in the discovery and development of innovative treatments for serious ocular diseases. With a robust pipeline focusing on conditions such as glaucoma and age-related macular degeneration, the company employs a scientifically rigorous approach to advance its lead drug candidate, trabodenoson INO-8875, which effectively addresses elevated intraocular pressure. The firm is supported by an experienced management team with a proven track record of successful New Drug Applications (NDAs), aiming to bring its clinical programs to commercialization. In addition to its advanced drug development platform, Inotek offers a range of effective, over-the-counter eye drops for glaucoma, ensuring high-quality products through collaboration with official suppliers and manufacturers. Generated from the website

Heritage Wealth Management works with a select group of individuals and families to preserve and grow their wealth by developing integrated investment solutions. Our process involves unique styles of management tailored to our clients' sophisticated needs and objectives.